Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids
- 30 November 1991
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 85 (6), 501-510
- https://doi.org/10.1016/s0954-6111(06)80268-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?Thorax, 1990
- Six-Month Double-Blind, Controlled Trial of High Dose, Concentrated Beclomethasone Dipropionate in the Treatment of Severe Chronic AsthmaChest, 1988
- Decreased adreno‐cortical suppression utilizing the Nebuhaler for inhalation of steroid aerosolsClinical and Experimental Allergy, 1987
- Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.Thorax, 1986
- High Dose Inhaled Budesonide in the Treatment of Severe Steroid‐Dependent AsthmaticsAllergy, 1985
- Use of Spacers to Facilitate Inhaled Corticosteroid Treatment of Asthma1–4American Review of Respiratory Disease, 1984
- Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function.Thorax, 1983
- HIGH-DOSE BECLOMETHASONE INHALER IN THE TREATMENT OF ASTHMAThe Lancet, 1983
- RECOVERY OF HYPOTHALAMO-PITUITARY-ADRENAL FUNCTION IN ASTHMATICS WHOSE ORAL STEROIDS HAVE BEEN STOPPED OR REDUCEDClinical Endocrinology, 1982
- A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthmaJournal of Allergy and Clinical Immunology, 1977